Virios Therapeutics Inc

NASDAQ:VIRI   4:00:00 PM EDT
1.64
-0.08 (-4.65%)
5:54:41 PM EDT: $1.63 -0.01 (-0.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Virios Therapeutics Inc Stock, NASDAQ:VIRI

44 Milton Avenue, Alpharetta, Georgia 30009
United States of America
Phone: +1.866.620.8655
Number of Employees: 4

Description

Virios Therapeutics, Inc. develops pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1, a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.